Natalie J Patel, MD
Pathology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Peninsula Pathologists Medical Group Inc · 17 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Patel’s office at (650) 616-2951 to ask if they take your plan before you enroll.
California Medical Board record
Licence A147231 · Current
Licensed to practise in California · since 2017 · expires 2028-11-30 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$71,338
Medicare paid this office $71,338 for 669 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 336 | $23,859 | $33 |
| Special stained specimen slides to examine tissue, each additional procedure | 100 | $11,333 | $25 |
| Pathology examination of tissue using a microscope, moderately high complexity | 83 | $9,204 | $73 |
| Special stained specimen slides to examine tissue, initial procedure | 192 | $7,816 | $31 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $3,554 | $132 |
See all 19 services
| Pathology examination of tissue using a microscope, intermediate complexity | 336 | $23,859 | $33 |
| Special stained specimen slides to examine tissue, each additional procedure | 100 | $11,333 | $25 |
| Pathology examination of tissue using a microscope, moderately high complexity | 83 | $9,204 | $73 |
| Special stained specimen slides to examine tissue, initial procedure | 192 | $7,816 | $31 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $3,554 | $132 |
| Protein measurement, serum | 136 | $3,220 | $16 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 41 | $2,171 | $34 |
| Pathology examination of specimen during surgery, first tissue block | 18 | $1,305 | $57 |
| Evaluation of fine needle aspirate with interpretation and report | 16 | $1,147 | $64 |
| Cell examination of specimen, selective cellular enhancement technique | 36 | $953 | $24 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $726 | $24 |
| Microscopic genetic analysis of tumor, manual | 11 | $676 | $38 |
| Special stained specimen slides to examine tissue including interpretation and report | 23 | $599 | $11 |
| Immunologic analysis technique on serum (immunofixation) | 33 | $584 | $16 |
| Pathology examination of tissue using a microscope, moderately low complexity | 50 | $535 | $10 |
| Protein measurement, body fluid | 26 | $421 | $16 |
| Preparation of tissue for examination by removing any calcium present | 24 | $293 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 60 | $264 | $4 |
| Examination of archival tissue for genetic analysis | 12 | $191 | $16 |
Who their Medicare patients are
669 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 17% · Women 53% · Also on Medicaid 14% · Health risk score 1.56. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Chronic kidney disease 35% · Diabetes 33% · Coronary heart disease 30% · Cancer 29% · Atrial fibrillation 24% · Depression 21% · Heart failure 19% · COPD 15% · Dementia 11% · Stroke 9%.
The office billed $304,670, Medicare allowed $90,427 and paid $71,338; for 2,317 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 669 | 2,317 | 77 | 1.56 | $304,670 | $71,338 |
| 2023 | 1,241 | 4,818 | 77 | 1.33 | $696,296 | $166,765 |
| 2022 | 864 | 3,622 | 76 | 1.27 | $538,607 | $128,144 |
| 2021 | 948 | 4,012 | 75 | 1.20 | $594,516 | $140,114 |
| 2020 | 990 | 4,387 | 75 | 1.29 | $656,883 | $159,361 |
| 2019 | 354 | 1,487 | 75 | 1.07 | $227,365 | $55,417 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Pathology examination of tissue using a microscope, intermediate complexity | 676 | $44,445 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 249 | $29,071 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 223 | $23,138 | $76 |
| Special stained specimen slides to examine tissue, initial procedure | 421 | $18,513 | $32 |
| Pathology examination of tissue using a microscope, high complexity | 78 | $12,490 | $134 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 150 | $9,252 | $35 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 32 | $5,203 | $163 |
| Cell examination of specimen, selective cellular enhancement technique | 125 | $3,555 | $25 |
| Evaluation of fine needle aspirate with interpretation and report | 47 | $3,488 | $65 |
| Microscopic genetic analysis of tumor, manual | 39 | $2,878 | $38 |
| Pathology examination of specimen during surgery, first tissue block | 38 | $2,763 | $58 |
| Protein measurement, serum | 106 | $2,382 | $16 |
| Special stained specimen slides to identify organisms including interpretation and report | 49 | $1,825 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 107 | $1,236 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 61 | $1,228 | $11 |
| Pathology examination of specimen during surgery | 24 | $784 | $33 |
| Genetic sequencing localization, initial procedure | 17 | $674 | $40 |
| Preparation of tissue for examination by removing any calcium present | 46 | $556 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 126 | $537 | $4 |
| Evaluation of fine needle aspirate | 14 | $461 | $33 |
| Examination of archival tissue for genetic analysis | 23 | $430 | $18 |
| Immunologic analysis technique on serum (immunofixation) | 15 | $277 | $15 |
| Protein measurement, body fluid | 12 | $196 | $16 |
2022: 21 services
| Pathology examination of tissue using a microscope, intermediate complexity | 511 | $36,751 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 200 | $21,244 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 158 | $20,764 | $77 |
| Special stained specimen slides to examine tissue, initial procedure | 324 | $13,625 | $32 |
| Pathology examination of tissue using a microscope, high complexity | 54 | $7,740 | $136 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 106 | $6,257 | $35 |
| Cell examination of specimen, selective cellular enhancement technique | 123 | $3,324 | $26 |
| Microscopic genetic analysis of tumor, manual | 39 | $3,059 | $39 |
| Pathology examination of specimen during surgery, first tissue block | 35 | $2,968 | $58 |
| Evaluation of fine needle aspirate with interpretation and report | 34 | $2,935 | $65 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 12 | $1,838 | $153 |
| Special stained specimen slides to identify organisms including interpretation and report | 39 | $1,490 | $24 |
| Special stained specimen slides to examine tissue including interpretation and report | 49 | $1,114 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 74 | $854 | $10 |
| Genetic sequencing localization, initial procedure | 20 | $852 | $41 |
| Pathology examination of specimen during surgery | 15 | $493 | $33 |
| Genetic sequencing localization, each additional procedure | 15 | $479 | $32 |
| Pathology examination of tissue using a microscope, limited examination | 106 | $474 | $4 |
| Preparation of tissue for examination by removing any calcium present | 22 | $277 | $12 |
| Examination of archival tissue for genetic analysis | 14 | $250 | $18 |
| Pathology examination of tissue using a microscope | 18 | $114 | $6 |
2021: 21 services
| Pathology examination of tissue using a microscope, intermediate complexity | 620 | $43,611 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 208 | $24,589 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 163 | $17,845 | $77 |
| Special stained specimen slides to examine tissue, initial procedure | 327 | $14,200 | $33 |
| Pathology examination of tissue using a microscope, high complexity | 60 | $8,871 | $136 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 124 | $7,565 | $36 |
| Microscopic genetic analysis of tumor, manual | 52 | $4,795 | $40 |
| Cell examination of specimen, selective cellular enhancement technique | 95 | $2,738 | $26 |
| Pathology examination of specimen during surgery, first tissue block | 39 | $2,728 | $58 |
| Evaluation of fine needle aspirate with interpretation and report | 31 | $2,484 | $65 |
| Special stained specimen slides to identify organisms including interpretation and report | 51 | $2,061 | $25 |
| Special stained specimen slides to examine tissue including interpretation and report | 63 | $1,426 | $11 |
| Genetic sequencing localization, initial procedure | 20 | $903 | $41 |
| Pathology examination of tissue using a microscope, moderately low complexity | 67 | $728 | $10 |
| Pathology examination of specimen during surgery, each additional tissue block | 17 | $705 | $29 |
| Examination of archival tissue for genetic analysis | 30 | $537 | $18 |
| Genetic sequencing localization, each additional procedure | 14 | $524 | $33 |
| Pathology examination of specimen during surgery | 12 | $400 | $33 |
| Pathology examination of tissue using a microscope, limited examination | 79 | $369 | $4 |
| Preparation of tissue for examination by removing any calcium present | 24 | $304 | $12 |
| Pathology examination of tissue using a microscope | 14 | $90 | $6 |
2020: 23 services
| Pathology examination of tissue using a microscope, intermediate complexity | 655 | $49,680 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 232 | $25,400 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 172 | $20,174 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 369 | $16,043 | $34 |
| Pathology examination of tissue using a microscope, high complexity | 59 | $9,965 | $140 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 126 | $7,875 | $37 |
| Evaluation of fine needle aspirate with interpretation and report | 55 | $5,391 | $67 |
| Microscopic genetic analysis of tumor, manual | 49 | $5,110 | $41 |
| Special stained specimen slides to identify organisms including interpretation and report | 66 | $2,888 | $26 |
| Pathology examination of specimen during surgery, first tissue block | 33 | $2,734 | $61 |
| Cell examination of specimen, selective cellular enhancement technique | 76 | $2,504 | $26 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 11 | $1,882 | $171 |
| Special stained specimen slides to examine tissue including interpretation and report | 68 | $1,419 | $11 |
| Genetic sequencing localization, initial procedure | 26 | $1,097 | $42 |
| Pathology examination of specimen during surgery | 29 | $1,002 | $33 |
| Pathology examination of tissue using a microscope, moderately low complexity | 74 | $862 | $11 |
| Genetic sequencing localization, each additional procedure | 19 | $732 | $33 |
| Pathology examination of specimen during surgery, each additional tissue block | 18 | $604 | $30 |
| Evaluation of fine needle aspirate | 16 | $523 | $33 |
| Examination of archival tissue for genetic analysis | 21 | $434 | $19 |
| Preparation of tissue for examination by removing any calcium present | 35 | $419 | $12 |
| Pathology examination of tissue using a microscope, limited examination | 82 | $374 | $4 |
| Pathology examination of tissue using a microscope | 13 | $98 | $7 |
2019: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 239 | $20,864 | $36 |
| Special stained specimen slides to examine tissue, each additional procedure | 71 | $6,770 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 58 | $5,999 | $79 |
| Special stained specimen slides to examine tissue, initial procedure | 99 | $4,154 | $34 |
| Pathology examination of tissue using a microscope, high complexity | 26 | $3,770 | $140 |
| Evaluation of fine needle aspirate with interpretation and report | 22 | $3,750 | $67 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 37 | $2,549 | $36 |
| Microscopic genetic analysis of tumor, manual | 15 | $1,600 | $40 |
| Evaluation of fine needle aspirate | 15 | $859 | $34 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $852 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 20 | $766 | $26 |
| Pathology examination of specimen during surgery, first tissue block | 11 | $657 | $60 |
| Special stained specimen slides to examine tissue including interpretation and report | 21 | $542 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 19 | $203 | $11 |
| Preparation of tissue for examination by removing any calcium present | 11 | $140 | $12 |
| Pathology examination of tissue using a microscope, limited examination | 27 | $123 | $4 |
Medicaid work
$437 in 2024
Medicaid paid $437 for 51 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 34 | $341 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 17 | $96 |
| 2024 | 51 | 2 | 20 | $437 |
| 2023 | 187 | 3 | 18 | $2,562 |
| 2022 | 30 | 2 | 14 | $350 |
| 2021 | 33 | 1 | 17 | $753 |
| 2020 | 26 | 1 | 14 | $461 |
| 2019 | 26 | 1 | 13 | $343 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 132 | $1,555 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 40 | $678 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $330 |
2022
| TISSUE EXAM BY PATHOLOGIST | 17 | $197 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $154 |
2021
| TISSUE EXAM BY PATHOLOGIST | 33 | $753 |
2020
| TISSUE EXAM BY PATHOLOGIST | 26 | $461 |
2019
| TISSUE EXAM BY PATHOLOGIST | 26 | $343 |
Money from drug and device companies
$16 in 2019
A payment is not proof that care is biased.
| Incyte | Jakafi | $16 | 1 payment
|
See the published payment
| Incyte | Meals · 2019-11-18 | Jakafi | $16 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760828420
- Licence
- CA A147231California A147231: Current · expires 2028-11-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 5700 Southwyck Blvd, Toledo, OH, 43614
- NPI first listed
- 2013-05-21
- NPI last updated
- 2020-01-31
- NPI record certified
- 2020-01-31
This is when the NPI record was last certified, not a medical board exam.